Mission; We strive to make contributions to humanity and society by supporting the best development of valuable drug candidates.
Origin of Our Company Name
There are a lot of hidden drug candidates in the world that holds great potential. We, as a portal platform company, hope to help turn these gemstones (hidden drug candidates) into brilliant gems (valuable new drugs). Our company’s name, Gemseki, was created by combining ”gemstone” and “genseki (gemstone in Japanese)” with hope of identifying these hidden drug candidates and turning them into valuable new drugs.
The mission of Gemseki Inc. is “We strive to make contributions to humanity and society by supporting the best development of valuable drug candidates.”
We position ourselves as a portal platform company, by providing the Drug Candidate Marketplace platform, to support the best use of hidden and untapped drug candidates by bridging companies who would like to introduce and/or license-out their drug candidates and companies who are eager to license-in the knowledge of these candidates to develop valuable new drugs.
By providing our services, we sincerely hope that valuable new drugs are made available to the society in efficient and timely manner, leading to countless amounts of patient’s lives to be saved.
All members of Gemseki Inc. strive and commit ourselves in making the sincere daily effort of turning hidden and untapped drug candidates (gemstones) into valuable new drugs (brilliant gems). I look forward to being able to share this new exciting endeavor and progress with you all, and am always grateful for your continued support.
President & CEO
|Company Name||Gemseki Inc.|
St Luke's Tower 28th Floor, 8-1 Akashi-cho, Chuo-ku, Tokyo,104-0044, Japan
TEL: +81 3 6264 0471
FAX: +81 3 5565 6160
Sumitomo Mitsui Banking Corporation Korai-bashi Building 9th Floor, 2-1-1 Fushimi-machi, Chuo-ku, Osaka, 541-0044, Japan
TEL: +81 6 6233 8420
FAX: +81 6 6233 8433
|Business Launch||October 2017|
|Representative||Ichiro Nagata (President & CEO)|
|Type of Business||1.Facilitating licensing activities of drug candidates & technologies
2.Investment (venture capital investment)